Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.
Journal article
Thornhill JP. et al, (2024), Aids, 38, 679 - 688
Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents.
Journal article
Sampson OL. et al, (2024), Front immunol, 15
Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population.
Journal article
Zacharopoulou P. et al, (2024), Front immunol, 15
Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions.
Journal article
Kopycinski J. et al, (2023), Sci rep, 13
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Journal article
Barnes E. et al, (2023), Nat med, 29, 1760 - 1774
Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery
Preprint
Ali M. et al, (2023)
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses.
Journal article
Dijokaite-Guraliuc A. et al, (2023), Cell rep, 42
Paediatric HIV slow-progression is associated with early CD8+ T-cell PD-1 expression and a stem-like phenotype.
Journal article
Adriano Vieira V. et al, (2023), Jci insight
Learning patterns of HIV-1 co-resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning
Preprint
Igiraneza AB. et al, (2023)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses.
Journal article
Murray SM. et al, (2022), Nat rev immunol, 1 - 13
A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117.
Journal article
Zacharopoulou P. et al, (2022), Curr opin hiv aids, 17, 352 - 358
Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV.
Journal article
Fidler S. et al, (2022), Clin infect dis
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
Journal article
Tuekprakhon A. et al, (2022), Cell
An exploration of how broadly neutralizing antibodies might induce HIV remission: the 'vaccinal' effect.
Journal article
Tipoe T. et al, (2022), Curr opin hiv aids, 17, 162 - 170
BreakAlign: a Perl program to align chimaeric (split) genomic NGS reads and allow visual confirmation of novel retroviral integrations.
Journal article
Marchi E. et al, (2022), Bmc bioinformatics, 23
The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial.
Journal article
Lee MJ. et al, (2022), Trials, 23
A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells.
Journal article
Sampson O. et al, (2022), J immunol methods, 504
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Journal article
Tomic A. et al, (2022), Nat commun, 13
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
Journal article
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58
Durability of ChAdOx1 nCov-19 vaccination in people living with HIV.
Journal article
Ogbe A. et al, (2022), Jci insight